What is the goal blood pressure in kidney transplant recipients?

Česká verzia

Authors: Tomáš Rohá
Authors place of work: Klinika nefrologie, Transplantcentrum, IKEM, Praha
Published in the journal: Vnitř Lék 2022; 68(6): 408-409
Category:
doi: https://doi.org/10.36290/vnl.2022.083

Summary

Arterial hypertension is a frequent condition after kidney transplantation and its treatment is a common agenda of the follow- up care. Retrospective data show that treatment of arterial hypertension decreases the risk of kidney graft loss. While randomized controlled trials for target blood pressures in kidney transplant recipients are not available, < 130/80 mm Hg is the most frequently mentioned value. Generally, all classes of antihypertensive drugs can be used, but it is important to consider timing after transplantation and possible interactions with immunosuppressive drugs.

Keywords:

kidney transplantation – arterial hypertension – guidelines – KDIGO

Zdroje

1. U.S. Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End‑Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010. Dostupné z WWW: <https://www.usrds.org/media/1309/v1_ckd_full_2010.pdf>.

2. Vella J, Brennan DC. Kidney transplantation in adults: Hypertension after kidney transplantation. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. https://www. uptodate.com. (cit. 2022-04-24).

3. Margreiter R. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomised multicentre study. Lancet. 2002;359(9308):741- 746.

4. Paoletti E, Gherzi M, Amidone M et al. Association of arterial hypertension with renal target organ damage in kidney transplant recipients: The predictive role of ambulatory blood pressure monitoring. Transplantation. 2009;87(12):1864-1869.

5. Tantisattamo E, Molnar MZ, Ho BT et al. Approach and Management of Hypertension After Kidney Transplantation. Front Med. 2020;7:229.

6. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Kidney Int. 1998;53(1):217-222.

7. Kasiske BL, Anjum S, Shah R et al. Hypertension after kidney transplantation. Am J Kidney, DiS. 2004;43(6):1071-1081.

8. Opelz G, Dohler B. Improved Long‑Term Outcomes After Renal Transplantation Associated with Blood Pressure Control. Am J Transplant. 2005;5(11):2725-2731.

9. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1-S87.

10. SPRINT Research Group, Wright JT, Williamson JD, et al. A Randomized Trial of Intensive versus Standard Blood‑ Pressure Control. N Engl J Med. 2015;373(22):2103-2116.

11. Widimský J Jr., Filipovský J, Ceral J et al. Doporučení pro diagnostiku a léčbu arteriální hypertenze ČSH 2017. Hypertenze & kardiovaskulární prevence. 2018; (Supplementum).

12. Cross NB, Webster AC, Masson P et al. Antihypertensive treatment for kidney transplant recipients. Cochrane Database Syst Rev. 2009;(3): CD003598.